Bulletin
Investor Alert

Johnson & Johnson

NYS: JNJ

GO
/marketstate/country/us

After Hours

JNJ
/zigman2/quotes/201724570/composite

$

145.85

Change

+0.19 +0.13%

Volume

Volume 284,968

Sep 25, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201724570/composite

Previous close

$ 144.67

$ 145.66

Change

+0.99 +0.68%

Day low

Day high

$143.89

$146.25

Open
Open: 144.00

52 week low

52 week high

$109.16

$157.00

Open

Market cap

$383.50B

Average volume

5.88M

P/E ratio

25.60

Rev. per Employee

$603,509

EPS

5.69

Dividend

1.01

Div yield

2.77%

Ex dividend date

8/24/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnj

MarketWatch News on JNJ

  1. Novavax stock soars after start of late-stage COVID-19 vaccine trial

    11:33 a.m. Today

    - Noah Manskar

  2. FDA to TikTok teens: the ‘Benadryl Challenge’ can kill you

    10:20 a.m. Today

    - Nicole Lyn Pesce

  3. Johnson & Johnson stock rises Friday, still underperforms market

    4:25 p.m. Sept. 25, 2020

    - MarketWatch Automation

  4. Covid-19 Vaccine Prices May Be Unexpectedly Low

    1:30 p.m. Sept. 25, 2020

    - Bill Alpert

  5. Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine

    9:07 a.m. Sept. 25, 2020

    - Bill Alpert

  6. Johnson & Johnson stock rises Thursday, still underperforms market

    4:25 p.m. Sept. 24, 2020

    - MarketWatch Automation

  7. Johnson & Johnson stock outperforms competitors on strong trading day

    4:25 p.m. Sept. 23, 2020

    - MarketWatch Automation

  8. Stocks’ Early Gains Fade Away

    4:18 p.m. Sept. 23, 2020

    - Barbara Kollmeyer

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/jnj

Other News on JNJ

  1. Wall Street Breakfast: What Moved Markets

    9:50 a.m. Today

    - Seeking Alpha

  2. Wall Street Breakfast: What Moved Markets

    9:50 a.m. Today

    - Seeking Alpha

  3. Retirement: The Near-Perfect Portfolio Revisited

    9:15 a.m. Today

    - Seeking Alpha

  4. Retirement: The Near-Perfect Portfolio Revisited

    9:15 a.m. Today

    - Seeking Alpha

  5. 5 Dividend Aristocrats To Buy And 5 Dividend Aristocrats To Avoid

    9:00 a.m. Today

    - Seeking Alpha

  6. BiomX: A Phage Platform Play

    3:49 p.m. Sept. 25, 2020

    - Seeking Alpha

  7. Seeking Alpha Catalyst Watch

    3:30 p.m. Sept. 25, 2020

    - Seeking Alpha

  8. Covid-19 Vaccines: What’s Coming and When?

    3:13 p.m. Sept. 25, 2020

    - Ana Rivas

  9. NVAX Stock: Novavax Rallies After Entering Phase 3 Vaccine Trials

    1:00 p.m. Sept. 25, 2020

    - InvestorPlace.com

  10. 7 Stocks You Can Buy to Help Save the Planet

    8:13 a.m. Sept. 25, 2020

    - InvestorPlace.com

  11. FDA issues final rule for importation of drugs from abroad

    7:21 a.m. Sept. 25, 2020

    - Seeking Alpha

  12. Covid-19 Vaccine From Novavax to Begin Phase 3 Trial in U.K.

    11:29 p.m. Sept. 24, 2020

    - Peter Loftus

  13. Credit Suisse Keeps a Buy Rating on Johnson & Johnson (JNJ)

    1:05 p.m. Sept. 24, 2020

    - SmarterAnalyst

  14. Loading more headlines...
/news/pressrelease/company/us/jnj

Press Releases on JNJ

  1. Precision Medicine Market Growing Trends and Demands Analysis forecast 2020 to 2026

    4:15 p.m. Today

    - Market Insight Reports

  2. Chesapeake Utilities to Join S&P SmallCap 600

    5:47 p.m. Sept. 25, 2020

    - PR Newswire - PRF

  3. Closing a Light Earnings Week

    9:38 a.m. Sept. 25, 2020

    - IAM Newswire

  4. Vaccine Updates

    10:12 a.m. Sept. 24, 2020

    - IAM Newswire

  5. Dow Movers: AXP, NKE

    10:25 a.m. Sept. 23, 2020

    - MarketNewsVideo.com

  6. Johnson & Johnson Leaps on Phase 3 Vaccine Test

    10:00 a.m. Sept. 23, 2020

    - Baystreet.ca

  7. Ulcerative Colitis Market Huge Growth Opportunities and Trends to 2026

    9:01 a.m. Sept. 23, 2020

    - Market Insight Reports

  8. Loading more headlines...

Rates »

Link to MarketWatch's Slice.